wow, what a great day....To buy more shares and warrants. TLT certainly has a knack of putting out muddled news releases that even seasoned investors have trouble making heads or tails of never mind newbies. Bottom line is that 4 out of 6 patients treated at the correct dosage have a complete response at 90 days for a CR of 66.6%. Without going into deeper details, the long term investors here know that the true results are 4 out of 5 patients with Complete Response at 90 days for a CR of 80%. I love buying shares in a proven company at a steep discount to true value that's trading under the radar in spite of its news releases. GLTA.